{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:43:14Z","timestamp":1793148194091,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> This study aims to systematically review the content and potential effects of clinical pharmacy services in tuberculosis (TB) care management.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Searches were performed in PubMed, Embase, Cochrane, Scopus, and Web of Science databases following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Study characteristics and outcomes were extracted, and clinical pharmacy service components were characterized using the Descriptive Elements of Pharmacist Intervention Characterization Tool.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty articles were included for full-text assessment, of which 10 fulfilled inclusion criteria, comprising 1,168 patients (<jats:italic>N<\/jats:italic> = 39 to 258 per study). These articles included five prospective cohort studies, two case\u2013control studies, two quasi-experimental studies, and one cross-sectional study. Intervention foci within clinical pharmacy services were medication adherence (50%), medication safety (40%), education to patients\/caregivers regarding needs\/beliefs (30%), optimizing medication\/therapy effectiveness (30%), emphasizing HRQoL (10%), and drug selections (10%). The three most frequently applied interventions were drug information\/patient counseling (80%), adverse drug reaction monitoring (50%), and drug use evaluation (20%). Based on the World Health Organization (WHO) outcome classification, treatment success ranged from 72% to 93%, with higher cure outcomes (53%\u201386%) than treatment completion (7%\u201319%). Other outcomes, including isoniazid metabolites, medication counts, sputum conversion, adherence\/compliance, knowledge, and quality of life, were better in the intervention group than those in comparator groups, and\/or they improved over time. Risk of bias analysis indicated that the included studies were not comparable to a randomized clinical trial.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Clinical pharmacy services as single or composite interventions potentially improve TB outcomes, but its evidence is still inconsistent and limited due to the lack of randomized controlled studies using the WHO outcome classification.<\/jats:p><jats:p><jats:bold>Systematic review registration:<\/jats:bold><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=199028<\/jats:ext-link>, identifier CRD42020199028.<\/jats:p>","DOI":"10.3389\/fphar.2023.1186905","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T12:26:57Z","timestamp":1688732817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical pharmacy services for tuberculosis management: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"D.","family":"Iskandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. D. A.","family":"Suryanegara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F. M.","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/TCRM.S118442","article-title":"Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast","volume":"12","author":"Abrogoua","year":"2016","journal-title":"Ivory Coast. Ther. Clin. risk Manag."},{"key":"B2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: An individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1183\/09031936.00180612","article-title":"Fixed-dose combination antituberculosis therapy: A systematic review and meta-analysis","volume":"42","author":"Albanna","year":"2013","journal-title":"Eur. Respir. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1002595","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1592\/phco.28.6.816","article-title":"The definition of clinical pharmacy","volume":"28","year":"2008","journal-title":"Pharmacotherapy"},{"key":"B6","first-page":"517","article-title":"Assessment and enhancing adherence to treatment regimen in tuberculosis out patients","volume":"4","author":"Bhardwaja","year":"2012","journal-title":"Int. J. Pharmcy Pharm. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s11096-020-01058-5","article-title":"Mapping the characteristics of meta-analyses of pharmacy services: A systematic review","volume":"42","author":"Bonetti","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2016.10.016","article-title":"Quality of tuberculosis care in high burden countries: The urgent need to address gaps in the care cascade","volume":"56","author":"Cazabon","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"0226507","DOI":"10.1371\/journal.pone.0226507","article-title":"Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis","volume":"14","author":"Chaves Torres","year":"2019","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2146\/ajhp050543","article-title":"Effect of pharmacist-led patient education on adherence to tuberculosis treatment","volume":"64","author":"Clark","year":"2007","journal-title":"Am. J. health-system Pharm. AJHP official J. Am. Soc. Health-System Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5588\/ijtld.17.0705","article-title":"A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis","volume":"22","author":"Cohen","year":"2018","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1345\/aph.1S006","article-title":"A tool to characterize the components of pharmacist interventions in clinical pharmacy services: The DEPICT project","volume":"47","author":"Correr","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"B14","unstructured":"Descriptive Elements of pharmacist intervention characterization tool: DEPICT manual of instructions2013"},{"key":"B15","doi-asserted-by":"crossref","unstructured":"Risk of bias in non-randomized studies of interventions (ROBINS-I): Detailed guidance2016","DOI":"10.1289\/isee.2016.3320"},{"key":"B16","article-title":"Pharmacotherapy","volume-title":"A pathophysiologic approach","author":"DiPiro","year":"2017"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s11096-016-0385-3","article-title":"Current perceptions of the term clinical pharmacy and its relationship to pharmaceutical care: A survey of members of the European society of clinical pharmacy","volume":"38","author":"Dreischulte","year":"2016","journal-title":"Int. J. Clin. Pharm."},{"key":"B18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11096-005-7060-4","article-title":"Defining clinical pharmacy and pharmaceutical care","volume":"27","author":"Franklin","year":"2005","journal-title":"Pharm. World Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: A cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: A systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1592\/phco.24.16.1491.50950","article-title":"Clinical pharmacy, pharmaceutical care, and the quality of drug therapy","volume":"24","author":"Hepler","year":"2004","journal-title":"Pharmacotherapy"},{"key":"B22","volume-title":"Introduction to hospital & health-system pharmacy practice","author":"Holdford","year":"2010"},{"key":"B23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijtb.2019.02.015","article-title":"Impact of pharmacist counseling and leaflet on the adherence of pulmonary tuberculosis patients in lungs hospital in Indonesia","volume":"66","author":"Karuniawati","year":"2019","journal-title":"Indian J. Tuberc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"876955","DOI":"10.3389\/fphar.2022.876955","article-title":"Assessment of adverse drug events, their risk factors, and management among patients treated for multidrug-resistant TB: A prospective cohort study from Pakistan","volume":"13","author":"Khan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1171985","DOI":"10.3389\/fphar.2023.1171985","article-title":"A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.ijtb.2020.11.009","article-title":"What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?","volume":"67","author":"Kumar","year":"2020","journal-title":"Indian J. Tuberc."},{"key":"B27","volume-title":"Impact of implementing a novel anti tuberculosis","author":"Kunoor","year":"2021"},{"key":"B28","doi-asserted-by":"publisher","first-page":"0159827","DOI":"10.1371\/journal.pone.0159827","article-title":"The effectiveness and safety of fluoroquinolone-containing regimen as a first-line treatment for drug-sensitive pulmonary tuberculosis: A systematic review and meta-analysis","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS ONE"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1590\/0001-3765201720170301","article-title":"Evaluation of the impact of pharmaceutical care for tuberculosis patients in a secondary referral outpatient clinic, minas gerais, Brazil","volume":"89","author":"Lopes","year":"2017","journal-title":"An. Acad. Bras. Ciencias"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-11775-7","volume-title":"Patient assessment in clinical pharmacy","author":"Mahmoud","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res. Syn. Meth"},{"key":"B32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12889-020-08562-3","article-title":"They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: Perspectives from patients and clinicians in the free state province, South Africa","volume":"20","author":"Moodley","year":"2020","journal-title":"BMC Public Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5365\/wpsar.2020.11.3.003","article-title":"Intensified research on tuberculosis in the western pacific region: A bibliometric analysis, 2000-2019","volume":"11","author":"Morishita","year":"2020","journal-title":"West. Pac Surveill. Response J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.5588\/ijtld.17.0596","article-title":"Interventions to improve adherence to tuberculosis treatment: Systematic review and meta-analysis","volume":"22","author":"M\u00fcller","year":"2018","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"0199706","DOI":"10.1371\/journal.pone.0199706","article-title":"A bibliometric analysis of tuberculosis research, 2007-2016","volume":"13","author":"Nafade","year":"2018","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.22376\/ijpbs\/lpr.2020.10.5.p6-10","article-title":"Impact of pharmacist counselling on knowledge, and medication adherence in tuberculosis patients: A quasi-experimental design","volume":"10","author":"Narayana","year":"2020","journal-title":"Int. J. Pharma Bio Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.sapharm.2019.03.007","article-title":"What does a pharmacist do? A time and motion study","volume":"16","author":"Negaard","year":"2020","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1080\/14656566.2016.1225724","article-title":"Antibiotic stewardship for drug resistant tuberculosis","volume":"17","author":"Padayatchi","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.rec.2021.07.010","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2146\/ajhp060335","article-title":"Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic review","volume":"64","author":"Phansalkar","year":"2007","journal-title":"Am. J. health-system Pharm. AJHP official J. Am. Soc. Health-System Pharm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11096-015-0137-9","article-title":"Effectiveness of clinical pharmacy services: An overview of systematic reviews (2000-2010)","volume":"37","author":"Rotta","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"B42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.sapharm.2016.01.003","article-title":"Characterization of published randomized controlled trials assessing clinical pharmacy services around the world","volume":"13","author":"Rotta","year":"2017","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.12669\/pjms.36.ICON-Suppl.1713","article-title":"The impact of structured counselling on patient knowledge at a private TB program in Karachi","volume":"36","author":"Sajjad","year":"2020","journal-title":"Pak J. Med. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"100093","DOI":"10.1016\/j.jctube.2019.100093","article-title":"Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS)","volume":"15","author":"Salehitali","year":"2019","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijid.2021.06.014","article-title":"Rate of treatment success and associated factors in the program for drug-susceptible tuberculosis in the forest region, republic of Guinea, 2010-2017: A real-world retrospective observational cohort study","volume":"110","author":"Schoenbaechler","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40545-022-00431-1","article-title":"Impact of pharmacist services on economic, clinical, and humanistic outcome (ECHO) of South asian patients: A systematic review","volume":"15","author":"Shrestha","year":"2022","journal-title":"J. Pharm. Policy Pract."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.cegh.2015.10.005","article-title":"Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis","volume":"3","author":"Singh","year":"2015","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"B49","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/jcpt.12746","article-title":"Effectiveness of pharmaceutical care on treatment outcomes for patients with first-time pulmonary tuberculosis in China","volume":"43","author":"Tang","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s41669-017-0057-9","article-title":"Out-of-Pocket expenditures, indirect costs and health-related quality of life of patients with pulmonary tuberculosis in Thailand","volume":"2","author":"Tanvejsilp","year":"2018","journal-title":"PharmacoEconomics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.japh.2019.06.015","article-title":"Examining the use of network meta-analysis in pharmacy services research: A systematic review","volume":"59","author":"Teoh","year":"2019","journal-title":"J. Am. Pharm. Assoc."},{"key":"B52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.22159\/ajpcr.2018.v11i2.20503","article-title":"Socio-epidemiological evaluation of tuberculosis and impact of pharmaceutical care on medication adherence among tuberculosis patients","volume":"11","author":"Thomas","year":"2018","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/ice.2021.422","article-title":"FAST tuberculosis transmission control strategy speeds the start of tuberculosis treatment at a general hospital in Lima, Peru","volume":"43","author":"Tierney","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/14787210.2017.1264270","article-title":"How do we measure adherence to anti-tuberculosis treatment?","volume":"15","author":"Valencia","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1183\/09031936.00125711","article-title":"Multidrug resistance after inappropriate tuberculosis treatment: A meta-analysis","volume":"39","author":"van der Werf","year":"2012","journal-title":"Eur. Respir. J."},{"key":"B56","first-page":"931","article-title":"Assessment of clinical pharmacist intervention to improve compliance and health care outcomes of tuberculosis patients","volume":"4","author":"Venkatapraveen","year":"2012","journal-title":"Der Pharm. Lett."},{"key":"B57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12879-018-3019-7","article-title":"Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in anqing, China: A retrospective study","volume":"18","author":"Wen","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2015.05.010","article-title":"Tuberculosis-related knowledge is associated with patient outcomes in shantytown residents; results from a cohort study, Peru","volume":"71","author":"Westerlund","year":"2015","journal-title":"J. Infect."},{"key":"B13","volume-title":"Clinical Pharmacy and Therapeutics","author":"Whittlesea","year":"2019"},{"key":"B59","volume-title":"Global investments in tuberculosis research and development: Past, present, and future","year":"2017"},{"key":"B60","volume-title":"Global tuberculosis report 2021","year":""},{"key":"B61","volume-title":"Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions: 17\u201319 november 2020","year":""},{"key":"B62","volume-title":"Multisectoral accountability framework: To accelerate progress to end tuberculosis by 2030","year":""},{"key":"B63","volume-title":"People-centred framework for tuberculosis programme planning and prioritization: User guide","year":""},{"key":"B64","volume-title":"The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015","year":"2014"},{"key":"B65","volume-title":"Treatment of tuberculosis: Guidelines","year":"2010"},{"key":"B66","volume-title":"WHO guidelines on tuberculosis infection prevention and control: 2019 update 2019 update","year":""},{"key":"B67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12941-017-0239-4","article-title":"Treating tuberculosis with high doses of anti-TB drugs: Mechanisms and outcomes","volume":"16","author":"Xu","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1186905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T12:27:26Z","timestamp":1688732846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1186905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":67,"alternative-id":["10.3389\/fphar.2023.1186905"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1186905","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"article-number":"1186905"}}